Personify Group, a strategic branding, communications, and growth advisory firm serving the dental industry, announced recently that Dr. Adam Silevitch, DMD, a board-certified pediatric dentist and clinical faculty member at Columbia University, has joined the company’s advisory board.
Dr. Silevitch brings a forward-thinking clinician’s perspective to Personify Group’s advisory team, with expertise spanning pediatric dentistry, minimally invasive treatment protocols, and emerging diagnostic technologies.
A practicing pediatric dentist, Dr. Silevitch is the founder of the Innovative Enamel Repair Protocol (IPERP), a clinical framework designed to promote proactive dental care through early diagnosis, remineralization strategies, and conservative treatment approaches. His work emphasizes early intervention and the use of advanced diagnostic technologies to identify enamel demineralization before cavitation occurs.
“Dr. Silevitch represents a new generation of clinical leadership in dentistry, one that prioritizes prevention, patient-centered care, and the intelligent use of emerging technologies,” said Michael Ventriello, Co-Founder and Chief Communications Officer of Personify Group. “His insights will help ensure that the companies and innovations we support remain grounded in real-world clinical workflows and positive patient outcomes.”
In addition to his New York private practice and academic role at Columbia University, Dr. Silevitch is a frequent speaker and educator on minimally invasive dentistry and modern clinical protocols. He collaborates with dental technology companies and industry organizations to help translate scientific innovation into practical solutions for everyday dental practice.
“Dentistry is undergoing a paradigm shift toward earlier diagnosis, preventive care, and technology-enabled clinical decision making,” Dr. Silevitch said. “I’m excited to work with Personify Group to help bridge the gap between innovation and everyday clinical practice.”
Through his advisory role, Dr. Silevitch will help Personify Group evaluate emerging dental technologies, support product development strategies, and contribute to educational initiatives designed to accelerate the adoption of preventive and minimally invasive care models.
According to Personify Group Co-Founder and Chief Branding Officer, Mark Ross, “Dr. Silevitch brings the rare combination of clinical credibility, forward-thinking innovation, and entrepreneurial insight that enables Personify Group to help shape solutions that truly resonate with clinicians and deliver better outcomes for their patients.”
About Personify Group
Personify Group is a strategic branding, communications, and growth advisory firm focused on the dental and oral health industry. The company works with emerging innovators and established dental organizations to develop brand narratives, industry visibility, and market adoption strategies that connect scientific innovation with real-world clinical practice.
Source: www.personifygroup.com
News 23 April 2026
Personify Group, a strategic branding, communications, and growth advisory firm serving the dental industry, announced today that Mason Kesner, a B2B/B2C commer
News 08 December 2025
Personify Group, dentistry’s brand growth partner, recently announced it has joined the Dental Trade Alliance (DTA), the national association representing suppliers, manufacturers and service...
News 12 December 2024
Introducing Personify Group: Dentistry’s Brand Growth Partner
Mark Ross and Michael Ventriello, the veteran dental marketing experts who introduced dentistry’s first virtual focus group platform, The Virtual Dental Team, as well as dentistry’s leading...
Pediatric dentistry 29 April 2026
Exploration and innovative application of digital technology in pediatric dentistry
Pediatric dentistry treats patients aged 0-18 years, encompassing the characteristics of general dentistry.
Pediatric dentistry 14 April 2026
Comparison between dexmedetomidine and esketamine in pediatric dentistry surgery
Dexmedetomidine (D) and esketamine (K) are used for the sedation of pediatric dental surgery. This study was designed to compare the effect of intranasal D and K in producing moderate sedation for...
Products 13 May 2026
The OsteoGen Plug® is the original and still the best clinically proven composite grafting plug
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth de
Delta Dental Plan of New Hampshire announces the election of three new members to its board.
Editorials 13 May 2026
Pictured left to right are students Cristina Estrada, JJ DeStefano-Malik and Sophia Chacon.
Oral pathology 13 May 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...